MRI Features for Predicting Microvascular Invasion and Postoperative Recurrence in Hepatocellular Carcinoma Without Peritumoral Hypointensity

References

• Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345–1362. doi:10.1016/S0140-6736(22)01200-4
   PubMed Web of Science ®Google Scholar
• Calderaro J, Seraphin TP, Luedde T, Simon TG. Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma. J Hepatol. 2022;76(6):1348–1361.
   PubMed Web of Science ®Google Scholar
• Rumgay H, Arnold M, Ferlay J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598–1606. doi:10.1016/j.jhep.2022.08.021
   PubMed Web of Science ®Google Scholar
• Erstad DJ, Tanabe KK. Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol. 2019;26(5):1474–1493. doi:10.1245/s10434-019-07227-9
   PubMed Web of Science ®Google Scholar
• Beaufrère A, Caruso S, Calderaro J, et al. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies. J Hepatol. 2022;76(2):343–352. doi:10.1016/j.jhep.2021.09.034
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhu M, Liu Y, Cao X, Zhang G, Yin L. Peritumoral imaging manifestations on Gd-EOB-DTPA-enhanced MRI for preoperative prediction of microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis. Front Oncol. 2022;12:907076. doi:10.3389/fonc.2022.907076
   PubMed Web of Science ®Google Scholar
• Hong SB, Choi SH, Kim SY, et al. MRI features for predicting microvascular invasion of hepatocellular carcinoma: a systematic review and meta-analysis. Liver Cancer. 2021;10(2):94–106. doi:10.1159/000513704
   PubMed Web of Science ®Google Scholar
• Rhee H, Cho ES, Nahm JH, et al. Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications. J Hepatol. 2021;74(1):109–121. doi:10.1016/j.jhep.2020.08.013
   PubMed Web of Science ®Google Scholar
• Kang HJ, Kim H, Lee DH, et al. Gadoxetate-enhanced MRI features of proliferative hepatocellular carcinoma are prognostic after surgery. Radiology. 2021;300(3):572–582. doi:10.1148/radiol.2021204352
   PubMed Web of Science ®Google Scholar
• Elsayes KM, Kielar AZ, Chernyak V, et al. LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance. J Hepatocell Carcinoma. 2019;6:49–69. doi:10.2147/JHC.S186239
   PubMed Web of Science ®Google Scholar
• Kim WR, Mannalithara A, Heimbach JK, et al. MELD 3.0: the model for end-stage liver disease updated for the modern era. Gastroenterology. 2021;161(6):1887–1895.e4. doi:10.1053/j.gastro.2021.08.050
   PubMed Web of Science ®Google Scholar
• Benchoufi M, Matzner-Lober E, Molinari N, Jannot AS, Soyer P. Interobserver agreement issues in radiology. Diagn Interv Imaging. 2020;101(10):639–641. doi:10.1016/j.diii.2020.09.001
   PubMed Web of Science ®Google Scholar
• He T, Zou J, Sun K, et al. Global research status and frontiers on microvascular invasion of hepatocellular carcinoma: a bibliometric and visualized analysis. Front Oncol. 2022;12:1037145. doi:10.3389/fonc.2022.1037145
   PubMed Web of Science ®Google Scholar
• Bai S, Yang P, Xie Z, et al. Preoperative estimated risk of microvascular invasion is associated with prognostic differences following liver resection versus radiofrequency ablation for early hepatitis b virus-related hepatocellular carcinoma. Ann Surg Oncol. 2021;28(13):8174–8185. doi:10.1245/s10434-021-09901-3
   PubMed Web of Science ®Google Scholar
• Lee S, Kang TW, Song KD, et al. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg. 2021;273(3):564–571. doi:10.1097/SLA.0000000000003268
   PubMed Web of Science ®Google Scholar
• Meng XP, Tang TY, Ding ZM, et al. preoperative microvascular invasion prediction to assist in surgical plan for single hepatocellular carcinoma: better together with radiomics. Ann Surg Oncol. 2022;29(5):2960–2970. doi:10.1245/s10434-022-11346-1
   PubMed Web of Science ®Google Scholar
• Zhang X, Li J, Shen F, Lau WY. Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol. 2018;33(2):347–354. doi:10.1111/jgh.13843
   PubMed Web of Science ®Google Scholar
• Zhang L, Yu X, Wei W, et al. Prediction of HCC microvascular invasion with gadobenate-enhanced MRI: correlation with pathology. Eur Radiol. 2020;30(10):5327–5336. doi:10.1007/s00330-020-06895-6
   PubMed Web of Science ®Google Scholar
• Jiang H, Wei H, Yang T, et al. VICT2 trait: prognostic alternative to peritumoral hepatobiliary phase hypointensity in HCC. Radiology. 2023;307(2):e221835. doi:10.1148/radiol.221835
   PubMed Web of Science ®Google Scholar
• Kitao A, Matsui O, Zhang Y, et al. Dynamic CT and gadoxetic acid-enhanced MRI characteristics of P53-mutated hepatocellular carcinoma. Radiology. 2023;306(2):e220531. doi:10.1148/radiol.220531
   PubMed Web of Science ®Google Scholar
• Tang M, Zhou Q, Huang M, et al. Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI. Eur Radiol. 2021;31(11):8615–8627. doi:10.1007/s00330-021-07941-7
   PubMed Web of Science ®Google Scholar
• Zhang L, Lin JB, Jia M, et al. Clinical and imaging features preoperative evaluation of histological grade and microvascular infiltration of hepatocellular carcinoma. BMC Gastroenterol. 2022;22(1):369. doi:10.1186/s12876-022-02449-w
   PubMed Web of Science ®Google Scholar
• Li YM, Zhu YM, Gao LM, et al. Radiomic analysis based on multi-phase magnetic resonance imaging to predict preoperatively microvascular invasion in hepatocellular carcinoma. World J Gastroenterol. 2022;28(24):2733–2747. doi:10.3748/wjg.v28.i24.2733
   PubMed Web of Science ®Google Scholar
• Huang M, Liao B, Xu P, et al. Prediction of microvascular invasion in hepatocellular carcinoma: preoperative Gd-EOB-DTPA-dynamic enhanced MRI and histopathological correlation. Contrast Media Mol Imaging. 2018;2018:9674565. doi:10.1155/2018/9674565
   PubMedGoogle Scholar
• Lee S, Kim KW, Jeong WK, et al. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation. Eur Radiol. 2020;30(2):987–995. doi:10.1007/s00330-019-06424-0
   PubMed Web of Science ®Google Scholar
• Mulé S, Galletto Pregliasco A, Tenenhaus A, et al. Multiphase liver MRI for identifying the macrotrabecular-massive subtype of hepatocellular carcinoma. Radiology. 2020;295(3):562–571. doi:10.1148/radiol.2020192230
   PubMed Web of Science ®Google Scholar
• Kim AY, Sinn DH, Jeong WK, et al. Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma. J Hepatol. 2018;68(6):1144–1152. doi:10.1016/j.jhep.2018.01.024
   PubMed Web of Science ®Google Scholar
• Lee S, Kim SH, Lee JE, Sinn DH, Park CK. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol. 2017;67(3):526–534. doi:10.1016/j.jhep.2017.04.024
   PubMed Web of Science ®Google Scholar
• Min JH, Lee MW, Park HS, et al. Interobserver variability and diagnostic performance of gadoxetic acid-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma. Radiology. 2020;297(3):573–581. doi:10.1148/radiol.2020201940
   PubMed Web of Science ®Google Scholar